REFILE-BRIEF-Photocure ASA to terminate the global licensing agreement for Lumacan

Mon Aug 18, 2014 5:37am EDT

(Refiles to add a code for Salix Pharmaceuticals ) Aug 18 (Reuters) - Photocure ASA : * Says agreed to terminate the global licensing agreement for Lumacan with Salix Pharmaceuticals * Says Will receive a payment of US$ 5M from Salix and will regain the global rights and all intellectual property to Lumacan. * Source text for Eikon * Further company coverage

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.